Primary Country (Mandatory)

Other Country (Optional)

Set News Language for United States

Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available

Set News Language for World

Primary Language (Mandatory)
Other Language(s) (Optional)

Set News Source for United States

Primary Source (Mandatory)
Other Source[s] (Optional)

Set News Source for World

Primary Source (Mandatory)
Other Source(s) (Optional)
  • Countries
    • India
    • United States
    • Qatar
    • Germany
    • China
    • Canada
    • World
  • Categories
    • National
    • International
    • Business
    • Entertainment
    • Sports
    • Special
    • All Categories
  • Available Languages for United States
    • English
  • All Languages
    • English
    • Hindi
    • Arabic
    • German
    • Chinese
    • French
  • Sources
    • India
      • AajTak
      • NDTV India
      • The Hindu
      • India Today
      • Zee News
      • NDTV
      • BBC
      • The Wire
      • News18
      • News 24
      • The Quint
      • ABP News
      • Zee News
      • News 24
    • United States
      • CNN
      • Fox News
      • Al Jazeera
      • CBSN
      • NY Post
      • Voice of America
      • The New York Times
      • HuffPost
      • ABC News
      • Newsy
    • Qatar
      • Al Jazeera
      • Al Arab
      • The Peninsula
      • Gulf Times
      • Al Sharq
      • Qatar Tribune
      • Al Raya
      • Lusail
    • Germany
      • DW
      • ZDF
      • ProSieben
      • RTL
      • n-tv
      • Die Welt
      • Süddeutsche Zeitung
      • Frankfurter Rundschau
    • China
      • China Daily
      • BBC
      • The New York Times
      • Voice of America
      • Beijing Daily
      • The Epoch Times
      • Ta Kung Pao
      • Xinmin Evening News
    • Canada
      • CBC
      • Radio-Canada
      • CTV
      • TVA Nouvelles
      • Le Journal de Montréal
      • Global News
      • BNN Bloomberg
      • Métro
How to pay for promising medications like Ozempic

How to pay for promising medications like Ozempic

ABC News
Wednesday, December 27, 2023 06:47:44 PM UTC

Semaglutide medications like Ozempic have been a breakthrough for health and diabetes management, but the medications require a prescription and can be expensive

Steve Haines always loved to go for walks, but exercise had become a nightmare when he was 380 pounds and diabetic. The 49-year-old from Champaign, Illinois, says he would get ulcers on his feet after long walks.

About six years ago, Haines’ doctor prescribed Ozempic, a medication approved by the Food and Drug Administration to treat diabetes that also helps with weight loss. Haines lost weight and began to feel more active. Now, at 220 pounds and with his diabetes under control, he gets out of the house a lot.

“I sometimes walk 10 to 15 miles in a day,” says Haines.

Haines is one of many Americans who live with diabetes. According to the Centers for Disease Control and Prevention, around 1 in 10 Americans have diabetes, and the vast majority have Type 2, a condition in which the body can’t control the amount of sugar in the blood.

Ozempic, generically known as semaglutide, can be a lifeline for many. Semaglutide stimulates insulin secretion and controls blood sugar, which helps manage Type 2 diabetes. The medication also slows digestion and sends signals to the brain that the stomach is full, which can lead to weight loss.

Read full story on ABC News
Share this story on:-
More Related News
© 2008 - 2025 Webjosh  |  News Archive  |  Privacy Policy  |  Contact Us